摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 901778-58-3

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
901778-58-3
化学式
C39H64N2O14Si3
mdl
——
分子量
869.199
InChiKey
BEPHRMNKDFFCOA-MNYCWKMRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.32
  • 重原子数:
    58.0
  • 可旋转键数:
    15.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.69
  • 拓扑面积:
    188.5
  • 氢给体数:
    0.0
  • 氢受体数:
    14.0

反应信息

  • 作为反应物:
    描述:
    4-二甲氨基吡啶N,N-二异丙基乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 1.0h, 生成 1-{N-methyl-N-[4-(allyl 2,3,4-tri-(O-tert-butyldimethylsilyl)-β-D-glucopyranosiduronate)-3-nitrobenzyloxycarbonyl]-2-aminoethoxycarbonyl}pyrrolidine-2,5-dione
    参考文献:
    名称:
    New Taxol® (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy
    摘要:
    Two new glucuronide paclitaxel prodrugs have been synthesized. Linked to the 2'-OH of the drug by a carbonate function, they include a self-immolative spacer bearing an arylnitro or arylamino group between the drug and the glucuronic acid residue. Both prodrugs were well detoxified and easily cleaved in the presence of beta-D-glucuronidase with fast removal of the spacer, releasing paclitaxel. The arylamino spacer-containing prodrug, more stable than the corresponding nitro analogue, was selected for further studies.
    DOI:
    10.1016/j.bmc.2006.03.002
  • 作为产物:
    描述:
    titanium(IV) isopropylate四丁基氟化铵溶剂黄146N,N-二异丙基乙胺 作用下, 以 四氢呋喃二氯甲烷N,N-二甲基甲酰胺甲苯 为溶剂, 反应 8.0h, 生成
    参考文献:
    名称:
    New Taxol® (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy
    摘要:
    Two new glucuronide paclitaxel prodrugs have been synthesized. Linked to the 2'-OH of the drug by a carbonate function, they include a self-immolative spacer bearing an arylnitro or arylamino group between the drug and the glucuronic acid residue. Both prodrugs were well detoxified and easily cleaved in the presence of beta-D-glucuronidase with fast removal of the spacer, releasing paclitaxel. The arylamino spacer-containing prodrug, more stable than the corresponding nitro analogue, was selected for further studies.
    DOI:
    10.1016/j.bmc.2006.03.002
点击查看最新优质反应信息